PKD1P4-NPIPA8: A Potential Drug Target and Biomarker (G110006323)

Target Name: PKD1P4-NPIPA8

NCBI ID: G110006323

PKD1P4-NPIPA8

Other Name(s): PKD1P4-NPIPA8 readthrough

PKD1P4-NPIPA8: A Potential Drug Target and Biomarker

PKD1P4-NPIPA8 is a protein that is expressed in the brain and is known to play a role in the regulation of pain signaling. Studies have shown that this protein is highly expressed in individuals with chronic pain and that it is involved in the development of neuroinflammation. This suggests that PKD1P4-NPIPA8 may be a promising drug target for the treatment of chronic pain.

The pain signaling pathway is a complex process that involves the activation of various neural elements, including neurotransmitters, ion channels, and signaling pathways. PKD1P4-NPIPA8 is involved in the regulation of this pathway and is thought to play a role in the regulation of pain.

One of the key functions of PKD1P4-NPIPA8 is its role in the regulation of neurotransmitter release. This protein is known to interact with several neurotransmitters, including GABA, which is a inhibitory neurotransmitter that plays a critical role in the regulation of pain signaling. Studies have shown that PKD1P4-NPIPA8 is involved in the regulation of GABA release and that this is a critical mechanism by which the protein helps to regulate pain.

Another function of PKD1P4-NPIPA8 is its role in the regulation of pain perception. This protein is thought to be involved in the regulation of pain perception and that its levels may be affected by various factors, including neuroinflammation. Studies have shown that PKD1P4-NPIPA8 is involved in the regulation of pain perception and that this is a critical mechanism by which the protein helps to regulate pain.

In addition to its role in the regulation of pain signaling and perception, PKD1P4-NPIPA8 is also involved in the regulation of neuroinflammation. This protein is thought to be involved in the regulation of neuroinflammation and that its levels may be affected by various factors, including inflammation and stress. Studies have shown that PKD1P4-NPIPA8 is involved in the regulation of neuroinflammation and that this is a critical mechanism by which the protein helps to regulate pain.

Given the involvement of PKD1P4-NPIPA8 in the regulation of pain signaling, neuroinflammation, and pain perception, this protein is a promising drug target for the treatment of chronic pain. Studies have shown that this protein is highly expressed in individuals with chronic pain and that it is involved in the development of neuroinflammation. This suggests that PKD1P4-NPIPA8 may be a promising drug target for the treatment of chronic pain.

In conclusion, PKD1P4-NPIPA8 is a protein that is expressed in the brain and is involved in the regulation of pain signaling, neuroinflammation, and pain perception. Studies have shown that this protein is highly expressed in individuals with chronic pain and that it is involved in the development of neuroinflammation. These findings suggest that PKD1P4-NPIPA8 may be a promising drug target for the treatment of chronic pain. Further research is needed to determine the exact role of PKD1P4-NPIPA8 in the regulation of pain and to develop effective treatments for this chronic pain.

Protein Name: PKD1P4-NPIPA8 Readthrough

The "PKD1P4-NPIPA8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PKD1P4-NPIPA8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets